我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

血管紧张素Ⅱ受体亚型Ⅰ拮抗剂应用的进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
1997年第4期
页码:
229-233
栏目:
综述
出版日期:
1997-08-01

文章信息/Info

Title:
-
作者:
麦炜颐　马　虹 综述
中山医科大学附属第一医院心内科　广州 510080
Author(s):
-
关键词:
受体;  血管紧张素　拮抗剂;  血管紧张素受体
Keywords:
-
分类号:
-
DOI:
-
文献标识码:
-
摘要:
-
Abstract:
-

参考文献/References

［1］Urata H, Kinoshita A ,Misono KS, et al. Identification of a highly specific chymase as the major angiotensin Ⅱ -forming enzyme in the human heart. J Biol Chem , 1990; 265 (36) : 22348.

[2]Peach MJ ,Dostal DE. The angiotensin Ⅱ receptor and the action of angiotensin Ⅱ. J Cardiovasc Pharmacol, 1990; 16 (suppl) : S25.

[3]Nakajima M , Horiuchi M , Morishita R, et al.Growth inhibitory formation of type 2 angiotensin Ⅱreceptor: Gain of function study by in vivo gene transter. Hypertension, 1994; 243(3) : 379.

[4]Munafo A , Chriaten Y, Nussberger J , et al.Drug concentration response relation-ships in normal volunteer′s after oral administration of losartan, an angiotensin Ⅱ receptor antagonist.Clin Pharmacol Ther, 1992; 51: 513.

[5]Gradman AH,Arcuri KE, Goldberg AT , et al. A randomized, placebo-controlled, double-blind,parallel study of various dose of Losartan potassium compared with Enalapril maleate in patients with essenital hypertension. Hypertension, 1995; 25 (6) : 1345.

[6]Soffer BA ,Wright JT Jr, Pratt JH, et al. Effects of losartan on a bankground of Hydrochlorothiazide in patients with hypertension. Hypertension, 1995; 26 (1) : 112.

[7]Camargo MJ , Von-Lutterotti N , Campbell WG Jr, et al. Control of blood pressure and end organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin Ⅱreceptor blockade. J Hypertens,1993; 11 (1) : 31.

[8]nada Y,Wada T , Shibouta Y, et al. Prevention of end-organ damages by a nonantihypertensive dose of TCV-116 in stroke-prone SHR(SHRSP). J Hypertens, 1994; 12 (S3) : S88.

[9]Gansevoort RT , de-Zeeuw D, de-Jong PE. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system.Kindney Int, 1994; 45: 861 .

[10]Raya TE, Fonken SJ , Lee RW , et al. Hemodynamic effects of direct angiotensin Ⅱ blockade compared to converting enzyme inhibition in rat model of heart. Am J Hypertens, 1991; 4: S334.

[11]Gottlieb SS,Dickstein K, Fleck E, et al. Hemodynamic and neurohormonal effects of the angiotensin Ⅱ receptor antagonist Losartan in patients with congestive heart failure. Circulation,1993; 88 (4) : 1602.

[12]Schiffer B,Wirger A ,Meybrunn M , et al. Compartive effects of chronic angiotensin converting enzyme inhibition and angiotensin Ⅱ type 1 receptor bolckade on cardiac remodeling after myocardial infarction in the rat. Circulation, 1994;89 (5) : 2273.

[13] Schuh JR,B lehm DJ , Frierdich GE, et al. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits.J Clin Invest, 1993; 91 (4) : 1453.

[14]Lafayette RA ,Mayer G, Park SK, et al. Angiontensin Ⅱ receptor blockade limits glomerular injury in rats with reduced renalmass. J Clin Invest, 1992; 90: 766.

[15]Anderson S, Jung FF, Ingelfinger JR, et al. Renal renin-angiotensin system in diabetes: functional, immunohistochemical and molecular biological correlations. Am J Physiol, 1993; 34:F477 .

[16] Bovee KC,Wong PC, Timmermans PB, et al. Effects of the nonpeptide angiotensin Ⅱ receptor antagonist DuP 753 on blood pressure and renal function in spontaneously hypertensive PH dogs. Am J Hypertens, 1991; 4: 334.

[17]Burnier M , Rutschmann B, Nussberger J , et al.Salt-dependent renal effects of an angiotensin Ⅱ antagonist in healthy subjects. H ypertension,1993; 22: 339.

.[18]Burnier M , Hagman M , Nussberger J , et al.Short-term and substained renal effects angiotensin Ⅱ receptor bolckade in healthy subjects. Hypertension, 1995; 25 (part1) : 602.

[19]Christen Y,Waeber B,Nussberger J , et al. Doseresponse relationship following oral adminstration of DuP 753 to normal humans. Am J Hypertens, 1991; 4: S350.

[20]Schalekamp MA ,Admiraal PJ ,Derkx FH. Estimation of regional metabolism and production of angiotensins in hypertensive subjects. Br J Clin Pharmacel, 1989; 28: 105S.

[21]Lacourciere Y,Brunner H, Irwin R, et al. Effects of modulotors of the renin-angiotensin-aldos-terone system on cough. J Hypertens, 1994; 12:1387.

[22]Goldberg MR, Tanaka W , Barchowsky A , et al.Effects of Losartan on blood pressurs, Plasma renin activity, and angiotensin Ⅱ in volunteers.Hypertension, 1993; 21: 704.

[23]Hajj-ali AF, Zimmerman BG. Kinin contribution to renal vasodilator effect of captopril inrabbit.Hypertension, 1991; 17: 504.

[24]Friberg P, Sundelin B,Bohman SO , et al. Reninangiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition or angiotensin Ⅱ antagonism. Kid Int,1994; 45: 485.

备注/Memo

备注/Memo:
收稿 1996-10-22；修回 1997-05-26
更新日期/Last Update: 1997-08-01